期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Modulation of protein fate decision by small molecules:targeting molecular chaperone machinery 被引量:2
1
作者 Lei Wang Xiaoli Xu +1 位作者 Zhengyu Jiang Qidong You 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2020年第10期1904-1925,共22页
Modulation of protein fate decision and protein homeostasis plays a significant role in altering the protein level,which acts as an orientation to develop drugs with new mechanisms.The molecular chaperones exert signi... Modulation of protein fate decision and protein homeostasis plays a significant role in altering the protein level,which acts as an orientation to develop drugs with new mechanisms.The molecular chaperones exert significant biological functions on modulation of protein fate decision and protein homeostasis under constantly changing environmental conditions through extensive protein-protein interactions(PPIs)with their client proteins.With the help of molecular chaperone machinery the processes of protein folding,trafficking,quality control and degradation of client proteins could be arranged properly.The core members of molecular chaperones,including heat shock proteins(HSPs)family and their co-chaperones,are emerging as potential drug targets since they are involved in numerous disease conditions.Development of small molecule modulators targeting not only chaperones themselves but also the PPIs among chaperones,co-chaperones and clients is attracting more and more attention.These modulators are widely used as chemical tools to study chaperone networks as well as potential drug candidates for a broader set of diseases.Here,we reviewed the key checkpoints of molecular chaperone machinery HSPs as well as their co-chaperones to discuss the small molecules targeting on them for modulation of protein fate decision. 展开更多
关键词 Molecular chaperone heat shock protein family Small molecule inhibitors protein fate protein-protein interaction
原文传递
Fibrolamellar hepatocellular carcinoma:Exploring molecular mechanisms and differentiation pathways to better understand disease outcomes and prognosis
2
作者 Cassandra A.Kersten Elise N.Sloey +3 位作者 Eric Zhou Ying Peng Michael S.Torbenson Yi Guo 《Liver Research》 2017年第4期187-192,共6页
Fibrolamellar hepatocellular carcinoma(FLC)is a rare but aggressive liver cancer of children that occurs predominantly in teenagers without a history of liver disease.Surgical resection remains the only therapeutic op... Fibrolamellar hepatocellular carcinoma(FLC)is a rare but aggressive liver cancer of children that occurs predominantly in teenagers without a history of liver disease.Surgical resection remains the only therapeutic option,and the recurrence rate is extremely high(>50%within 3 years).A newly discovered chromosomal deletion that occurs in the majority of FLCs generates a novel kinase fusion between DnaJ heat shock protein family member B1(DNAJB1)and protein kinase cAMP-activated catalytic subunit alpha(PRKACA)(DNAJB1-PRKACA).Despite its high penetrance and apparent specificity for FLC,the oncogenic role of this fusion event remains unclear.In this review article,we discuss the histology,presentation and diagnosis,current treatment,and roles of the DNAJB1-PRKACA as well as research models contributing to our understanding of this disease. 展开更多
关键词 Fibrolamellar hepatocellular carcinoma(FLC) DnaJ heat shock protein family member B1 (DNAJB1) protein kinase cAMP-activated catalytic subunit alpha(PRKACA)Pediatric cancer Liver cancer
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部